FIELD: medicine.
SUBSTANCE: what is presented is a differential diagnostic technique for type 1 and 2 cordaron-induced thyrotoxicosis. In addition to thyroid ultrasound and colour Doppler flow mapping, thyreotrophin receptor antibody titre is to be determined. If the antibody titre occurred to be more than 1.5 IU/l, type 1 cordaron-induced thyrotoxicosis is diagnosed. If the antibody titre is found to be less than 1.0 IU/l, type 2 cordaron-induced thyrotoxicosis is diagnosed.
EFFECT: invention provides effective diagnosing of type 1 and 2 cordaron-induced thyrotoxicosis.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING RADIOIODINE THERAPY FOR GRAVES' DISEASE | 2022 |
|
RU2791390C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF ENDOCRINE OPHTHALMOPATHY IN PATIENTS WITH GRAVES DISEASE BY DETECTING ANTI-THYROID PEROXIDASE ANTIBODIES | 2011 |
|
RU2460072C1 |
| PANEL FOR DETERMINING PREDISPOSITION TO THE DEVELOPMENT OF DISORDERS OF THE FUNCTIONING OF THE THYROID SYSTEM AND ITS USE | 2022 |
|
RU2784603C1 |
| METHOD FOR EARLY DIAGNOSIS OF AN ACTIVE PHASE OF ENDOCRINE OPHTHALMOPATHY | 2018 |
|
RU2687082C1 |
| METHOD FOR INDIVIDUAL PRESCRIPTION OF SYSTEMIC GLUCOCORTICOSTEROID PULSE THERAPY IN PATIENTS WITH ENDOCRINAL OPHTHALMOPATHY | 2012 |
|
RU2503011C1 |
| METHOD FOR PERSONALIZED APPROACH TO CHOOSING METHOD FOR TREATMENT OF GRAVES DISEASE | 2022 |
|
RU2794815C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF IODINE-DEFICIENCY AND IODINE-INDUCED THYROID DYSFUNCTION IN INDIVIDUALS LIVING IN REGIONS WITH IODINE DEFICIENCY | 2019 |
|
RU2728261C2 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF RELAPSE IN THE MEDICAL TREATMENT OF GRAVES' DISEASE | 2021 |
|
RU2778614C1 |
| METHOD FOR PREDICTING DIFFUSE TOXIC GOITER CLINICAL COURSE | 2005 |
|
RU2291434C1 |
| PREDICT THE RISK OF MALIGNANCY OF THE NODAL FORMATIONS IN PATIENTS WITH ENDOCRINOLOGICAL DISEASES | 2017 |
|
RU2657417C1 |
